Sign in
ONCO Stock Price, Chart, Stats & News
Onconetix, Inc.
Save
Onconetix, Inc. (ONCO) does not currently pay a dividend.
377,453
Market cap
–
Current P/E
–
Forward P/E
ONCO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 77.62% |
Operating margin | -2190.03% |
Pretax margin | -1720.91% |
Net margin | -1720.98% |
Effective tax rate | -0.00% |
ROA | -56.29% |
ROE | -189.85% |
D/E | 0.00x |
Interest coverage ratio | -23.78x |
ONCO valuation
P/E | – |
P/S | 8.15x |
P/B | 0.40x |
P/CF | -0.66x |
P/FCF | -0.69x |
P/OCF | -0.66x |
PEG | -0.39x |
EV multiple | -0.58x |
About
Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The company's product lineup includes Entadfi, an FDA-cleared, once-daily oral medication. This prescription drug combines finasteride and tadalafil to manage benign prostatic hyperplasia (BPH).
Similar securities
Based on sector and market capitalization
Report issue